HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peng Li Selected Research

Parenteral Infusions

1/2017Better Clinical Efficiency of TILs for Malignant Pleural Effusion and Ascites than Cisplatin Through Intrapleural and Intraperitoneal Infusion.
3/2016Effective Treatment for Malignant Pleural Effusion and Ascites with Combined Therapy of Bevacizumab and Cisplatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peng Li Research Topics

Disease

398Neoplasms (Cancer)
01/2023 - 03/2002
112Infections
08/2022 - 04/2003
80Inflammation (Inflammations)
10/2022 - 04/2006
68Carcinogenesis
10/2022 - 08/2007
58Neoplasm Metastasis (Metastasis)
07/2022 - 07/2002
56Hepatocellular Carcinoma (Hepatoma)
05/2022 - 03/2006
52Breast Neoplasms (Breast Cancer)
10/2022 - 11/2007
48Hypoxia (Hypoxemia)
08/2021 - 08/2003
39Fibrosis (Cirrhosis)
05/2022 - 09/2006
35Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 12/2005
34Obesity
12/2021 - 01/2007
31Body Weight (Weight, Body)
04/2022 - 06/2006
31Stomach Neoplasms (Stomach Cancer)
01/2022 - 09/2008
30Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 06/2006
28Hypertension (High Blood Pressure)
03/2022 - 02/2008
27Wounds and Injuries (Trauma)
01/2023 - 08/2005
25Insulin Resistance
04/2022 - 10/2007
24Reperfusion Injury
01/2022 - 09/2003
23Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 02/2008
22Atherosclerosis
04/2022 - 01/2012
21Lung Neoplasms (Lung Cancer)
01/2022 - 09/2005
19Alzheimer Disease (Alzheimer's Disease)
09/2022 - 07/2007
19Pain (Aches)
06/2022 - 01/2011
19Carcinoma (Carcinomatosis)
03/2022 - 05/2004
19Necrosis
01/2022 - 03/2004
18Myocardial Infarction
05/2022 - 02/2006
18Ischemia
02/2019 - 03/2004
16Colonic Neoplasms (Colon Cancer)
09/2022 - 12/2005
16Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 12/2013
15Disease Progression
02/2022 - 10/2004
15Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2012
15Esophageal Squamous Cell Carcinoma
12/2019 - 01/2009
14Hemorrhage
06/2022 - 09/2003
14COVID-19
01/2022 - 01/2020
14Stroke (Strokes)
12/2021 - 07/2007
13Mitochondrial Diseases (Mitochondrial Disease)
10/2022 - 07/2007
13Neuroinflammatory Diseases
06/2022 - 08/2013
13Type 2 Diabetes Mellitus (MODY)
04/2022 - 02/2010
13Heart Failure
01/2022 - 11/2005
13Thrombosis (Thrombus)
12/2021 - 01/2012
13Leukemia
08/2020 - 01/2013
12Cognitive Dysfunction
04/2022 - 02/2016
12Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2022 - 06/2005
12Fatty Liver
03/2022 - 10/2007
12Lymphoma (Lymphomas)
01/2022 - 11/2011
12Parkinson Disease (Parkinson's Disease)
01/2022 - 09/2011
12Adenocarcinoma
01/2021 - 04/2006
11Schizophrenia (Dementia Praecox)
01/2022 - 05/2009

Drug/Important Bio-Agent (IBA)

162Proteins (Proteins, Gene)FDA Link
10/2022 - 09/2002
89Biomarkers (Surrogate Marker)IBA
09/2022 - 11/2003
62Pharmaceutical PreparationsIBA
09/2022 - 08/2006
52CytokinesIBA
09/2022 - 05/2009
52Biological ProductsIBA
03/2022 - 08/2004
51MicroRNAs (MicroRNA)IBA
08/2022 - 03/2012
48Messenger RNA (mRNA)IBA
09/2021 - 09/2002
38LipidsIBA
09/2022 - 02/2008
30Long Noncoding RNAIBA
10/2022 - 01/2011
28Therapeutic UsesIBA
06/2022 - 12/2006
28Glucose (Dextrose)FDA LinkGeneric
05/2022 - 08/2012
25AntigensIBA
09/2022 - 08/2006
24Peptides (Polypeptides)IBA
09/2022 - 04/2002
23LigandsIBA
09/2022 - 10/2002
23Phosphotransferases (Kinase)IBA
01/2022 - 12/2009
23CollagenIBA
12/2021 - 07/2003
21RNA (Ribonucleic Acid)IBA
10/2022 - 10/2002
21Chimeric Antigen ReceptorsIBA
09/2022 - 01/2016
21EnzymesIBA
02/2022 - 08/2005
21Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2008
20DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2004
19AntioxidantsIBA
05/2022 - 02/2006
18Transcription Factors (Transcription Factor)IBA
05/2022 - 10/2002
17Hormones (Hormone)IBA
12/2021 - 08/2004
17Small Interfering RNA (siRNA)IBA
12/2021 - 11/2011
17Caspase 3 (Caspase-3)IBA
01/2021 - 01/2013
16Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 04/2003
15Indicators and Reagents (Reagents)IBA
01/2022 - 11/2007
15NF-kappa B (NF-kB)IBA
05/2021 - 09/2003
14Circular RNAIBA
01/2022 - 01/2017
14Enterotoxin ReceptorsIBA
11/2013 - 12/2005
13Immune Checkpoint InhibitorsIBA
07/2022 - 01/2017
13Insulin (Novolin)FDA Link
04/2022 - 10/2013
13CateninsIBA
01/2022 - 04/2015
13VaccinesIBA
01/2022 - 05/2006
13InterleukinsIBA
01/2021 - 08/2005
12LipopolysaccharidesIBA
06/2022 - 01/2014
12Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 02/2006
12Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 06/2014
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020 - 08/2003
11InflammasomesIBA
07/2022 - 09/2014
11HydrogelsIBA
04/2022 - 04/2011
11Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 03/2010
11C-Reactive ProteinIBA
01/2022 - 08/2005

Therapy/Procedure

154Therapeutics
01/2023 - 04/2002
47Drug Therapy (Chemotherapy)
04/2022 - 06/2006
33Immunotherapy
07/2022 - 07/2008
18Transplantation
03/2022 - 11/2008
15Aftercare (After-Treatment)
01/2022 - 06/2005
12Ligation
05/2022 - 09/2011
12Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2022 - 12/2013
12Radiotherapy
01/2022 - 05/2004